Sarepta
- All
- News
-
"Why Were We Kept In Dark?": Delhi High Court On Rare Disease Clinical Trial
The Delhi High Court on Wednesday expressed its displeasure over being "kept in dark" about an ongoing trial here for Duchenne Muscular Dystrophy (DMD) when it has been dealing with issues pertaining to indigenous treatment of the rare disease.
-
Ebola Drug Trials to be Fast-Tracked in West Africa
Experimental Ebola drugs including compounds from Mapp Biopharmaceutical, Sarepta and Tekmira will be tested in affected West African states for the first time in a bid to fast-track trials, the Wellcome Trust said on Tuesday.
-
Twitter, social media fertile ground for stock hoaxes
Prominent short-seller David Einhorn raised eyebrows last month when he popped up on Twitter to disavow that he had tweeted about Herbalife Ltd.
-
Second Twitter hoax in two days, knocks off another stock
Sarepta Therapeutics Inc became the second company in as many days to see its shares plunge as a result of a Twitter hoax.
-
"Why Were We Kept In Dark?": Delhi High Court On Rare Disease Clinical Trial
The Delhi High Court on Wednesday expressed its displeasure over being "kept in dark" about an ongoing trial here for Duchenne Muscular Dystrophy (DMD) when it has been dealing with issues pertaining to indigenous treatment of the rare disease.
-
Ebola Drug Trials to be Fast-Tracked in West Africa
Experimental Ebola drugs including compounds from Mapp Biopharmaceutical, Sarepta and Tekmira will be tested in affected West African states for the first time in a bid to fast-track trials, the Wellcome Trust said on Tuesday.
-
Twitter, social media fertile ground for stock hoaxes
Prominent short-seller David Einhorn raised eyebrows last month when he popped up on Twitter to disavow that he had tweeted about Herbalife Ltd.
-
Second Twitter hoax in two days, knocks off another stock
Sarepta Therapeutics Inc became the second company in as many days to see its shares plunge as a result of a Twitter hoax.
